We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+9.19%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$1.15B
AUM Growth
+$59M
Cap. Flow
-$87.2M
Cap. Flow %
-7.58%
Top 10 Hldgs %
12.78%
Holding
1,132
New
384
Increased
172
Reduced
194
Closed
306

Top Buys

Rank Stock Value
1
CEF icon
Sprott Physical Gold and Silver Trust
CEF
+$12.8M
2
JIH.U
Juniper Industrial Holdings, Inc. Units, each consisting of one share of Class A common stock, $0.00
JIH.U
+$9.53M
3
ZAGG
ZAGG Inc Common Stock (Delaware)
ZAGG
+$8.79M
4
AMZN icon
Amazon
AMZN
+$6.74M
5
BABA icon
Alibaba
BABA
+$6.59M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$15.9M
2
CELG
Celgene Corp
CELG
+$15M
3
AABA
Altaba Inc
AABA
+$10.1M
4
BMTX
BM Technologies, Inc.
BMTX
+$9.25M
5
GCMG icon
GCM Grosvenor
GCMG
+$8.1M

Sector Composition

Rank Sector Weight
1 Technology 13.52%
2 Healthcare 10.04%
3 Consumer Discretionary 6.7%
4 Real Estate 4.77%
5 Communication Services 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CFRX
801
DELISTED
ContraFect Corporation
CFRX
$39K ﹤0.01%
78
– –
KA
802
DELISTED
Kineta, Inc. Common Stock
KA
$37K ﹤0.01%
117
-869
-88% -$195K
ALGRR
803
DELISTED
Allegro Merger Corp Right
ALGRR
$35K ﹤0.01%
110,300
+27,575
+33% +$8.83K
ABEO icon
804
Abeona Therapeutics
ABEO
$369M
$33K ﹤0.01%
+400
New +$28.2K
TOTAR
805
DELISTED
Tottenham Acquisition I Limited Right expiring 3/6/2021
TOTAR
$32K ﹤0.01%
175,000
– –
TOVX icon
806
Theriva Biologics
TOVX
$9.64M
$30K ﹤0.01%
240
– –
NIHD
807
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$28K ﹤0.01%
13,000
-307,209
-96% -$594K
CREX icon
808
Creative Realities
CREX
$39.6M
$27K ﹤0.01%
5,949
-751
-11% -$3.58K
PAACR
809
DELISTED
Proficient Alpha Acquisition Corp. Rights
PAACR
$26K ﹤0.01%
125,000
– –
LITS
810
Lite Strategy Inc
LITS
$33.6M
$25K ﹤0.01%
+500
New +$18.6K
MTNB icon
811
Matinas BioPharma
MTNB
$2.03M
$23K ﹤0.01%
+200
New +$11.6K
CSCI
812
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$22K ﹤0.01%
241
-372
-61% -$34.7K
MRNS
813
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$22K ﹤0.01%
+2,500
New +$14K
CREXW
814
DELISTED
Creative Realities, Inc. Warrant
CREXW
$19K ﹤0.01%
12,500
– –
VIRX
815
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$16K ﹤0.01%
1,392
– –
IZEA icon
816
IZEA Worldwide
IZEA
$59.2M
$15K ﹤0.01%
15,375
– –
ABBV icon
817
AbbVie
ABBV
$455B
– –
-14,073
Closed -$1.07M
ACEL icon
818
Accel Entertainment
ACEL
$973M
– –
-20,000
Closed -$206K
ACRS icon
819
Aclaris Therapeutics
ACRS
$743M
– –
-11,700
Closed -$13K
ADBE icon
820
CALL
Adobe
ADBE
$98.5B
– –
-122
Closed -$3.37M
AEIS icon
821
Advanced Energy
AEIS
$11B
– –
-9,433
Closed -$542K
AEO icon
822
American Eagle Outfitters
AEO
$2.9B
– –
-87,100
Closed -$1.41M
AIFA
823
All In FutureTech Alliance Inc
AIFA
$9.76M
– –
-2,503
Closed -$79K
AGS
824
DELISTED
PlayAGS
AGS
– –
-12,133
Closed -$125K
AKBA icon
825
Akebia Therapeutics
AKBA
$362M
– –
-71,000
Closed -$278K
31 32
33
34 35

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return

Boothbay Fund Management's Q4 2019 Portfolio in Review

As of Q4 2019, Boothbay Fund Management held 1,132 positions worth $1.15B, up 5.4% from $1.09B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boothbay Fund Management withdrew a net $87.2M in Q4 2019, closing 306 positions and reducing 194 holdings. Its most notable exit was Celgene Corp, an estimated $15M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Boothbay Fund Management opened a new position in Juniper Industrial Holdings, Inc. Units, each consisting of one share of Class A common stock, $0.00 worth $9.4M.

  • Boothbay Fund Management's largest Q4 2019 buy was Juniper Industrial Holdings, Inc. Units, each consisting of one share of Class A common stock, $0.00: 949,000 shares worth $9.4M.
  • Boothbay Fund Management added most to Sprott Physical Gold and Silver Trust in Q4 2019, an estimated $12.8M increase.
  • Boothbay Fund Management's biggest Q4 2019 reduction was Alphabet (Google) Class A, cutting an estimated $15.9M.
  • Boothbay Fund Management fully exited Celgene Corp in Q4 2019, selling an estimated $15M.
  • Boothbay Fund Management's ten largest holdings make up 13% of its $1.15B portfolio in Q4 2019.
  • Boothbay Fund Management opened 384 new positions and closed 306 in Q4 2019.
  • Boothbay Fund Management's portfolio value rose 5.4% quarter-over-quarter to $1.15B.

Based on Boothbay Fund Management's 13F filing for Q4 2019, filed 14 Feb 2020.